EATG » Access

Access

ViiV Healthcare’s commitments to accelerate the availability of dolutegravir for the treatment of HIV in children

As a specialist HIV company, ViiV Healthcare (ViiV) is committed to addressing the ongoing challenges and gaps in treatment options and management of HIV treatment in children and adolescents. We…

Desperate Venezuela HIV patients, unable to get life-saving drugs, try DIY remedies

It’s like Venezuela has returned to the 1980s, when people used to take shark cartilage and cat’s claw to treat HIV, before antiretroviral medications became the norm. This crisis is…

MSF at AIDS 2018: press releases, updates, publications

Press releases/Updates   Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine As the annual global HIV/AIDS conference gets underway in Amsterdam, Médecins Sans Frontières…

AIDS 2018: Catalysing zero discrimination in health-care settings in Thailand and Viet Nam

Stigma and discrimination in health-care settings is a major obstacle to ending AIDS. Widespread across the world, stigma and discrimination seriously reduces the quality of life of people who experience…

Oppositions filed against Gilead hepatitis C patent applications in India

Oppositions have been filed in India against two patent applications from US pharmaceutical company Gilead for important hepatitis C medicines, according to non-governmental sources. The opposition filings assert that these…

New partnership to help fast-track affordable HIV medicine for children living with HIV

We are delighted to announce the joint launch of a partnership to speed up development and introduction of optimized pediatric formulations of dolutegravir for children living with HIV in resource-limited…

Merck reinforces commitment to responsible pricing

KENILWORTH, N.J., July 19, 2018 -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, has a long history of responsible pricing. In 2017, Merck issued its second…

How to ensure access to essential medicines for all? New WHO report reviews medicines reimbursement policies in Europe

The new WHO report “Medicines reimbursement policies in Europe” examines the various policies that increase access to affordable medicines. Based on direct data collection from 45 of the 53 countries…

NHS England and local authorities must ensure routine availability of PrEP for HIV prevention by 1 April 2019, says coalition of charities

• 32 organisations demand HIV prevention drug PrEP to be routinely available on the NHS by 1 April 2019 • The current three-year trial will provide PrEP to 10,000 people…

The Netherlands: After years of foot-dragging: a meager PrEP decision with no ambition

July 11, 2018: Yesterday, Dutch Minister of Health, Welfare and Sport Bruno Bruins announced his plan to provide PrEP for the next five years to a group of gay men…